#elililly

  • Weekly Giveaway for our active users. N50,000 per Week. Do you want to contribute to this community? We are looking for contribution? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing Nigerian forum!
  1. A

    Eli Lilly Stock Plummets After Disappointing Q3 Earnings Report.

    Earnings and Revenue Shortfall Eli Lilly (LLY) faced a significant drop in its stock price, plummeting over 13% in early trading following its third-quarter earnings release, marking its worst day since August 9, 2000. The company reported total revenues of $11.4 billion, which fell...
  2. A

    WEIGHTWATCHERS TO OFFER COMPOUNDED VERSION OF WEGOVY.

    WeightWatchers announced its plan to offer a compounded version of Novo Nordisk's weight-loss drug, Wegovy, as part of its weight-management programs. This announcement led to a nearly 47% surge in WeightWatchers' stock price, marking its highest closing in over two months. The decision comes...
  3. A

    ELI LILLY TO INVEST $4.5 BILLION IN STATE-OF-THE-ART DRUG MANUFACTURING AND CLINICAL TRIAL MEDICINE PRODUCTION SIGNIFICANT INVESTMENT IN INNOVATION.

    Eli Lilly and Company has announced a monumental $4.5 billion investment to establish the Lilly Medicine Foundry, a cutting-edge facility dedicated to drug manufacturing and clinical trial medicine production. This facility will be built in the LEAP Research and Innovation District in Lebanon...
  4. A

    Eli Lilly Expands Access to Zepbound with Affordable Single-Dose Vials for Obesity Treatment

    Eli Lilly and Company (NYSE: LLY) has launched Zepbound® (tirzepatide) single-dose vials, available through its LillyDirect® self-pay channel, significantly expanding access to obesity treatment. These vials are priced at least 50% lower than other incretin (GLP-1) medicines for obesity...
Top Bottom